Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

M.Video-Eldorado completes loyalty programs mergers

9/16/24 MVID

Owner of Ozon warehouse that burned down in 2022 sued for ₽3.7 billion

9/16/24 OZON

Shareholders of Ashinskiy metallurgical works approved dividend

9/16/24 AMEZ

Softline started placement of 76 million shares of additional share issue

9/16/24 SOFL

Globaltrans plans to delist from the Moscow Exchange

9/13/24 GLTR

Shareholders of Diasoft approved dividends

9/13/24 DIAS

Yandex.Market launches wholesale supplies from China

9/13/24 YDEX

SFI's share was acquired by a subsidiary of RussNeft

9/12/24 RNFT

Fesco launched a container train from Vladivostok to Togliatti

9/12/24 FESH

Yandex launched an analog of the Miro service

9/12/24 YDEX